Suppr超能文献

非酒精性脂肪性肝炎患者循环中的内脏脂肪素及其与胰岛素敏感性、脂联素和肝脏组织学的关系。

Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis.

作者信息

Genc Halil, Dogru Teoman, Tapan Serkan, Kara Muammer, Ercin Cemal Nuri, Aslan Fatih, Kantarcioglu Murat, Karslioglu Yildirim, Sertoglu Erdim, Erbil Mehmet Kemal, Bagci Sait

机构信息

Department of Gastroenterology, Gulhane Medical School, Ankara, Turkey.

出版信息

Scand J Gastroenterol. 2011 Nov;46(11):1355-61. doi: 10.3109/00365521.2011.603163. Epub 2011 Jul 19.

Abstract

OBJECTIVE

Non-alcoholic steatohepatitis (NASH) is closely associated with components of metabolic syndrome. Vaspin is a novel adipocytokine that may link obesity, insulin resistance (IR), and type 2 diabetes mellitus. We aimed to investigate circulating vaspin levels in subjects with NASH and also to search for the association of vaspin with IR, adiponectin, and histological findings.

MATERIAL AND METHODS

A total of 50 male patients with NASH and 30 healthy male controls were enrolled. Vaspin and adiponectin were measured with ELISA method. Insulin sensitivity determined by homeostasis model assessment (HOMA-IR) index.

RESULTS

Plasma vaspin levels were higher and adiponectin levels were lower in NASH group compared with controls (p < 0.01 and p < 0.001, respectively). However, in multivariate analysis adjusted for glucose and lipid parameters, and HOMA-IR indexes, the difference in vaspin concentrations was disappeared. Nonetheless, the difference regarding the adiponectin levels remained significant between groups (p = 0.03). Vaspin was negatively correlated with low-density lipoprotein cholesterol (r = -0.32, p = 0.03) in subjects with NASH.

CONCLUSIONS

This study indicates that circulating vaspin levels are not altered in male subjects with NASH. These results suggest that in the absence of metabolic risk factors, vaspin per se may not be involved in the pathogenesis of NASH.

摘要

目的

非酒精性脂肪性肝炎(NASH)与代谢综合征的各组分密切相关。内脏脂肪素是一种新型脂肪细胞因子,可能与肥胖、胰岛素抵抗(IR)及2型糖尿病相关。我们旨在研究NASH患者的循环内脏脂肪素水平,并探寻内脏脂肪素与IR、脂联素及组织学结果之间的关联。

材料与方法

共纳入50例男性NASH患者及30例健康男性对照。采用酶联免疫吸附测定(ELISA)法检测内脏脂肪素和脂联素。通过稳态模型评估(HOMA-IR)指数测定胰岛素敏感性。

结果

与对照组相比,NASH组血浆内脏脂肪素水平较高,脂联素水平较低(分别为p < 0.01和p < 0.001)。然而,在对血糖、血脂参数及HOMA-IR指数进行校正的多变量分析中,内脏脂肪素浓度差异消失。尽管如此,两组间脂联素水平差异仍具有统计学意义(p = 0.03)。在NASH患者中,内脏脂肪素与低密度脂蛋白胆固醇呈负相关(r = -0.32,p = 0.03)。

结论

本研究表明,男性NASH患者的循环内脏脂肪素水平未发生改变。这些结果提示,在无代谢危险因素的情况下,内脏脂肪素本身可能不参与NASH的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验